Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 21.05B | 22.00B | 18.34B | 16.26B | 16.66B | 14.60B |
Gross Profit | 15.39B | 22.11B | 17.48B | 15.25B | 15.72B | 13.78B |
EBITDA | 1.08B | 1.33B | 1.42B | 909.00M | 1.57B | 0.00 |
Net Income | 793.00M | 717.00M | 902.00M | 517.00M | 617.00M | 415.00M |
Balance Sheet | ||||||
Total Assets | 128.21B | 118.67B | 97.62B | 84.90B | 92.17B | 84.66B |
Cash, Cash Equivalents and Short-Term Investments | 7.91B | 5.50B | 63.66B | 55.98B | 63.78B | 60.37B |
Total Debt | 5.73B | 5.04B | 4.43B | 4.36B | 3.85B | 3.96B |
Total Liabilities | 116.72B | 107.77B | 88.45B | 77.73B | 79.16B | 70.30B |
Stockholders Equity | 11.40B | 10.82B | 9.08B | 7.08B | 13.01B | 14.35B |
Cash Flow | ||||||
Free Cash Flow | 5.06B | 9.37B | 4.04B | 1.34B | 4.16B | 3.29B |
Operating Cash Flow | 5.06B | 9.37B | 4.04B | 1.34B | 4.18B | 3.32B |
Investing Cash Flow | -10.52B | -12.54B | -4.07B | -5.69B | -4.63B | -2.68B |
Financing Cash Flow | 4.72B | 3.66B | 78.00M | 4.44B | 20.00M | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | $11.38B | 6.17 | 18.75% | 0.65% | 23.19% | -22.42% | |
78 Outperform | $2.17B | 6.64 | 14.07% | ― | 35.36% | -3.34% | |
75 Outperform | $14.09B | 17.24 | 5.52% | 2.41% | 10.40% | -71.67% | |
73 Outperform | $11.72B | 15.41 | 7.07% | 2.01% | 1.53% | -10.27% | |
71 Outperform | $2.28B | 19.69 | 7.20% | ― | -5.57% | -44.54% | |
65 Neutral | $440.93M | 9.70 | 7.04% | ― | 5.21% | -57.04% | |
62 Neutral | C$15.13B | 6.84 | 19.02% | 5.62% | 33.28% | -19.39% |
On July 31, 2025, RGA Reinsurance Company, a subsidiary of Reinsurance Group of America, entered into reinsurance agreements with subsidiaries of Equitable Holdings, Inc., covering a 75% quota share of approximately $32 billion in life insurance liabilities. This transaction is part of a master agreement announced in February 2025. The company also reported its second-quarter results, noting a net income of $180 million, or $2.70 per diluted share, and adjusted operating income of $315 million, or $4.72 per diluted share. While the second quarter results were below expectations due to claims volatility, RGA highlighted strong new business and balance sheet optimization efforts, with an increase in estimated excess capital to $3.8 billion. The company remains optimistic about its growth prospects and continues to focus on its strategic initiatives.
The most recent analyst rating on (RGA) stock is a Buy with a $244.00 price target. To see the full list of analyst forecasts on Reinsurance Group stock, see the RGA Stock Forecast page.
On June 4, 2025, Reinsurance Group of America, Incorporated completed a significant transaction involving the issuance and sale of $1 billion in Pre-Capitalized Trust Securities (P-Caps) through Omnis Funding Trust. This strategic move provides the company with contingent liquidity for general corporate purposes and involves a complex arrangement with various financial institutions. The transaction includes the issuance of Senior Notes and a facility agreement, which outlines conditions under which the company can exercise rights related to these notes. This development is poised to impact the company’s financial operations and market positioning by enhancing its liquidity management capabilities.
The most recent analyst rating on (RGA) stock is a Buy with a $239.00 price target. To see the full list of analyst forecasts on Reinsurance Group stock, see the RGA Stock Forecast page.
On May 21, 2025, Reinsurance Group of America held its annual shareholders meeting where amendments to the Flexible Stock Plan and Phantom Stock Plan for Directors were approved, increasing the number of shares authorized for issuance. The amendments do not affect any previous awards to the company’s executives. Additionally, shareholders voted on the election of eleven directors and other proposals, including the approval of executive compensation and the ratification of Deloitte & Touche LLP as the independent auditor for the fiscal year ending December 31, 2025. The meeting saw participation from approximately 92% of the company’s outstanding voting shares.
The most recent analyst rating on (RGA) stock is a Buy with a $227.00 price target. To see the full list of analyst forecasts on Reinsurance Group stock, see the RGA Stock Forecast page.